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Abstract: We examined the dose–response effect of MnCl2 on the proliferative behavior of
triple-negative breast cancer MDA-M231 cells vs. immortalized HB2 cells from breast epithelium
taken as nontumoral counterparts. We also tested the effect of MnCl2 on tumor cell invasiveness
in vitro by evaluating the relative invasion indexes through Boyden chamber assays. Moreover,
we checked whether cotreatment with both MnCl2 and CdCl2 could modify the observed biological
response by MDA-MB231 cells. Our results show a promotional impact of MnCl2 on cell proliferation,
with 5 µM concentration inducing the more pronounced increase after 96-h exposure, which is not
shared by HB2 cells. Exposure to 5 µM MnCl2 induced also an elevation of the relative invasion index
of cancer cells. The Mn-mediated stimulatory effects were counteracted by cotreatment with CdCl2.
These data support the concept that human exposure to high environmental concentrations of Mn
may increase the risk of carcinogenesis and metastasis by prompting the expansion and dissemination
of triple-negative breast cancer cells. On the other hand, the Mn-counteracting anticancer property
of Cd looks promising and deserves a more detailed characterization of the involved intracellular
targets aimed to the molecular modeling of specific antineoplastic agents against malignant breast
cancer spreading.
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1. Introduction
Manganese (Mn) is a natural occurring element in the earth’s crust where it represents the twelfth
most abundant one. It is not found in nature as a pure metal but as a component of several inorganic
and organic compounds. In industry, the major implementations of Mn include steel production and
the alloying of aluminum. The major dietary source of Mn for humans is vegetables, e.g., cereals,
whole grain, and nuts, and usually Mn intake from food is higher than that from water. However,
since the environmental concentration of the metal may be elevated by anthropogenic activities such
as industrial emissions, fossil fuel combustion, and use of pesticides, this can result in its release
into and contamination of drinking water with consequent increase of human exposure. At cellular
level, Mn is an essential micronutrient which can be found as a component of a broad variety of
metalloenzymes involved in processes related to energy production, general metabolism, bone and
connective tissue formation, and blood clotting [1,2]. Mn uptake by mammalian cells is mediated
by different transporters, such as the divalent metal transporter -1 (DMT-1) and Zrt- and Irt-like
proteins (ZIP) 8 and 14 [3,4], which show affinity also for other divalent metals, i.e., cadmium (Cd) and
zinc (Zn).
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Triple-negative breast cancers (TNBC) are characterized by a highly “aggressive” malignant
potential thereby being usually associated with worse prognosis than other breast tumor types,
due to the lack of expression of estrogen and progesterone receptors and HER2/neu, which renders
these neoplastic cells poorly responsive to hormonal therapies and to HER2-targeting drugs [5].
A number of case–control studies have found a significant association between serum Mn levels and
the development of malignant breast cancer in humans [6,7] and rodents [8], thus prompting a more
detailed biological investigation of the cellular and molecular implications of breast cell exposure to Mn.
To this purpose, the MDA-MB231 cell line represents a suitable model system in vitro, being derived
from a pleural effusion of a TNBC of basal subtype and displaying several aspects of a highly malignant
phenotype, e.g., the inactivation of p53 dependent upon a mutation in codon 280 and the ability to
metastasize in vivo [9–11]. The number of studies concerning the effect of Mn on MDA-MB231 cells
that can be found in the literature is limited. In particular, Lymburner et al. [12] demonstrated that,
among other divalent cations, Mn acts as the strongest promoter of integrin-mediated adhesion of
MDA-MB231 cells to fibronectin, whereas Ju et al. [13] reported a downregulation of MDA-MB231 cell
growth and motility in the presence of Mn-12 acetate.
In the present study we have investigated the dose–response effect of different concentrations
of MnCl2 on MDA-M231 cell viability/growth comparing cell behavior with that of immortalized
HB2 cells from breast epithelium taken as a nontumoral counterpart. We have further examined the
effect of MnCl2 on TNBC cells with respect to invasiveness in vitro by evaluating specific parameters
such as invasion index (I.I.) and relative invasion index (R.I.I.). Moreover, taking into consideration
that Mn and Cd share and compete for the same membrane transporters [14–16] and that we [17–19]
previously demonstrated and characterized the cytotoxic effect exerted by exposure of MDA-MB231
cells to CdCl2, we checked whether coexposure of MDA-MB231 cells to both MnCl2 and CdCl2
could somehow modify the biological response of TNBC cells with respect to the treatment with the
sole MnCl2.
2. Results
2.1. Influence of MnCl2 on Cell Proliferative and Invasive Behavior In Vitro
In the first set of assays we checked the effect of exposure to increasing concentrations of MnCl2
for various time lapses on the proliferative behavior of MDA-MB231 TNBC cells via crystal violet assay.
In addition, parallel experiments were performed on HB2, an immortalized cell line obtained from
breast epithelium, taken as a non-neoplastic counterpart. Figure 1A shows the dose- and time-response
histograms of viability/growth of MDA-MB231 cells as the percentage of dye absorbance in wells
with respect to controls. The data obtained indicate that 96-h treatments with 1, 5, 10, and 50 µM
MnCl2 determined an approximate 32, 52, 47, and 32% increase of cell population, respectively,
although an initial decrease of cell number could be observed in the presence of 10 and 50 µM
concentrations of the molecule. The dose–time response pattern after exposure to 100 µM MnCl2
was symptomatic of a viability- and growth-restraining activity exerted by the molecule at this high
concentration on the breast cancer cell line. On the other hand, as shown in Figure 2B, when HB2 cells
were submitted to the same analysis for comparison, their proliferative behavior was not remarkably
modified by the presence of MnCl2, and, also in this case, at the higher concentrations tested, i.e., 50 and
100 µM, the number of attached cells was found to diminish over time.
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Figure 1. Effect of exposure of MDA-MB231 (A) and HB2 (B) cells to different concentrations of 
MnCl2 for 24, 48, 72, and 96 h. The histogram shows the percent ratio between the crystal violet 
absorbance of exposed cells and that of untreated controls. Four replicates were run for each assay. 
The results are expressed as the mean ± standard error of the mean (SEM) from quadruplicate assays. 
Four replicates were run for each assay. * p < 0.05. 
 
Figure 2. Representative low-magnification images captured at 6-h showing that control, (A) 5 µM 
MnCl2-treated (B), and 100 µM MnCl2-treated cells (C) migrated through the filter pores in the 
chemotaxis assays. Microscopic magnification = 40×. (D) Histogram showing the number of migrated 
cells in chemotaxis (black bars) and chemoinvasion assays (gray bars) in the two experimental 
conditions. The results are expressed as the mean ± standard error of the mean (SEM) of six different 
experiments. 
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for 24, 48, 72, and 96 h. The histogram shows the percent ratio between the crystal violet absorbance of
exposed cells and that of untreated controls. Four replicates were run for each assay. The results are
expressed as the mean ± standard error of the mean (SEM) from quadruplicate assays. Four replicates
were run for each assay. * p < 0.05.
   x FOR PEER REVIEW 3 of  
 
 
Figure 1. Effect of exposure of MDA-MB231 (A) and HB2 (B) cells to different concentrations of 
MnCl2 for 24, 48, 72, and 96 h. The histogram shows the percent ratio between the crystal violet 
absorbance of exposed cells and that of untreated controls. Four replicates were run for each assay. 
The results are expressed as the mean ± standard error of the mean (SEM) from quadruplicate assays. 
Four replicates were run for each assay. * p < 0.05. 
 
Figure 2. Representative low-magnification images captured at 6-h showing that control, (A) 5 µM 
MnCl2-treated (B), and 100 µM MnCl2-treated cells (C) migrated through the filter pores in the 
chemotaxis assays. Microscopic magnification = 40×. (D) Histogram showing the number of migrated 
cells in chemotaxis (black bars) and chemoinvasion assays (gray bars) in the two experimental 
conditions. The results are expressed as the mean ± standard error of the mean (SEM) of six different 
experiments. 
ifi ti i es t re t - i t t tr l,
2-treated ( ), 2-treated ce ls ( ) i r te t r t fi
fi ti . (D) Histogra sho i t
in chemotaxis (black bars) and chemoinvasion assays (gray bars) in the two exp rimental conditions.
The result are expressed as the mean ± standard error of the mean (SEM) of six different exper ments.
Molecules 2019, 24, 1205 4 of 12
We then extended our study of MnCl2 effects on MDA-MB231 cancer cells by examining their
locomotory and invasive behavior in vitro after exposure for 96 h to either 5 or 100 µM concentrations
of the molecule, which in the proliferation assays induced higher increase and decrease of the cell
population, respectively. When cells were cultured in these two experimental conditions, as shown in
Figure 2, an opposite modulation of cell motility in Boyden chamber assays was observed.
In fact, the average migration ratio between either 5- or 100 µM MnCl2-exposed cells and controls
was 0.45 and 1.9, respectively, in the chemotaxis assays, and 0.8 and 1.4 in the chemoinvasion assays.
In light of the data obtained, we calculated the I.I.s and the R.I.I., a parameter which, taking
both cell chemotactic and chemoinvasive behaviors into consideration, is useful to extrapolate the
actual modulation of in vitro invasiveness within the general phenomenon of cell mobilization
(see e.g., Luparello, C.; et al. [9]). Although the general motile attitude appeared to increase in cells
treated with 100 µM MnCl2, when I.I.s and R.I.I.s were evaluated, exposure to 5 µM MnCl2 appeared
to upregulate drastically the ability of the subpopulation of locomotion-triggered cells to penetrate the
three-dimensional matrix (control cells’ I.I. = 0.36; treated cells’ I.I. = 1; R.I.I. = 2.78), whereas exposure
to 100 µM concentration of the molecule, which promoted the motility of a larger cell population,
resulted in a slight downregulation of cell invasive potential (control cells’ I.I. = 0.36; treated cells’
I.I. = 0.33; R.I.I. = 0.92).
2.2. Effect of Coexposure to MnCl2 and CdCl2 on Cell Proliferative and Invasive Behavior In Vitro
We have previously reported that CdCl2 is able to restrain MDA-MB231 cell viability and growth
with an IC50 of 5 µM at 96-h [17]. Therefore, in a second set of experiments we examined the
effect of addition of 5 µM CdCl2 in the experimental conditions previously tested on MDA-MB231
cell proliferative behavior after 96-h exposure. Figure 3 shows the dose–response histogram as the
percentage of dye absorbance in wells with respect to controls, i.e., cells treated with MnCl2 only.
The data obtained indicate that CdCl2 was able to decrease cell growth down to ~22–27% of controls
in all the experimental conditions tested, including treatment with 100 µM MnCl2 that was the sole
condition where no upregulation of cell number was found. Therefore, this result gives evidence that
coexposure to CdCl2 determines a generalized reversion of MnCl2-induced promotion of MDA-MB231
cell proliferative behavior.
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Figure 3. Effect of coexposure of MDA-MB231 cells to both 5 µM CdCl2 and different concentrations
of MnCl2 for 96 h. The histogram shows the percent ratio between the crystal violet absorbance of
coexposed cells and that of controls, i.e., cells treated with the sole MnCl2 at the indicated concentrations.
Results are from quadruplicate crystal violet assays. Four replicates were run for each assay. The results
are expressed as the mean ± standard error of the mean (SEM).
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The effect of coexposure of MnCl2 with 5 µM CdCl2 on cell invasive behavior was also
checked. Therefore, in preliminary assays we evaluated MDA-MB231 cell behavior in chemotaxis and
chemoinvasion assays after exposure for 96 h to 5 µM CdCl2. Figure 4 shows that, in line with the
previously observed inhibitory effect on cell viability and growth [17], CdCl2 treatment determined
a decrease of cell chemotactic ability with an average migration ratio between exposed and control cells
of 0.66. Analogously, we found a decrease also in cell chemoinvasive ability through three-dimensional
reconstituted basement membrane, the average migration ratio accounting for 0.57. The average I.I.s
of control and treated cells were found to account for 77 and 67, respectively, and consequently the
average R.I.I. of treated cells was 0.87 thus confirming the invasion-restraining effect of cell exposure
to CdCl2.
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Figure 4. Representative low-magnification images captured at 6 h showing control (A) and
5 µM CdCl2-treated MDA-MB231 cells (B) migrated through the filter pores in chemotaxis assays.
Microscopic magnification = 40×. (C) Histogram showing the number of migrated cells in chemotaxis
(black bars) and chemoinvasion assays (gray bars) in the two experimental conditions. The results are
expressed as the mean ± standard error of the mean (SEM) of six different experiments.
In light of the observed stimulatory role played by MnCl2 on cell motility or invasiveness in
Boyden chamber tests, we examined whether the addition of 5 µM CdCl2 in MnCl2-containing media
could induce any change in the locomotory or invasive attitude of breast cancer cells. Figure 5 shows
that CdCl2 was able to downregulate the effect of MnCl2 on cell invasive potential shown in Figure 2.
In particular, the coexposure to 5 µM MnCl2 appeared to determine an average migration ratio vs.
controls (i.e., cell exposed to 5 µM MnCl2 only) of 0.5 in both chemotaxis and chemoinvasion tests,
respectively, whereas in the case of cotreatment with 100 µM MnCl2, the average migration ratio vs.
controls (i.e., cell exposed to 100 µM MnCl2 only) decreased down to 0.19 and 0.14 in chemotaxis
and chemoinvasion tests, respectively. On the other hand, when the R.I.I.s were quantitated their
values appeared to diminish in both experimental conditions of coexposure, being 1 in the presence of
5 µM MnCl2 (control cells’ I.I. = 1, co-treated cells’ I.I. = 1) and 0.75 in the presence of 100 µM MnCl2
(control cells’ I.I. = 0.33, cotreated cells’ I.I. = 0.25).
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3. Discussion
In the present paper, we have tested the effect of increasing concentrations of MnCl2 on the
proliferative, locomotory, and invasive behavior of TNBC MDA-MB231 cells. All the concentrations
chosen, including the lowest one, i.e., 1 µM, are higher than those estimated in healthy adults’
physiological fluids such as blood and milk [20,21], and therefore the experimental conditions are
representative of states of moderate to intense environmental contamination. Noteworthy, in their
early case–control study Mulay et al. [22] demonstrated the increase of Mn concentration in malignant
human breast tissues with respect to their normal counterparts, whereas Dearth et al. [8] reported
that exposure of prepubertal rats to environmentally relevant high Mn concentrations increases
their susceptibility to breast cancer risk via upregulation of ERα and associated proteins. In line
with these observations, our first set of data on cell proliferative behavior show a promotional
impact of MnCl2, except for the highest concentration tested of 100 µM, which is not shared by
non-neoplastic HB2 breast cells. Interestingly, in previous experiments HB2 cells resulted insensitive
also to the cytotoxic effect of CdCl2 when administered at a concentration equivalent to the IC50
at 96 h for MDA-MB231 cells [17]. When breast cancer cells were assayed for their motility and
invasiveness through matrigel after exposure to the two MnCl2 concentrations exerting opposite
growth effects after 96 h of incubation, i.e., 5 and 100 µM, they exhibited a stimulation of their
motile, but not invasive, attitude in the presence of the higher concentration, whereas those cultured
in 5 µM MnCl2-containing medium appeared endowed also with a marked upregulation of their
invasive, other than proliferative, phenotype. It is known that, in addition to the activation of the
locomotory ability, highly invasive MDA-MB231 subpopulations selected using Boyden chambers
display (i) the upregulation of urokinase-plasminogen activator (uPa)/uPa receptor expression and of
metalloproteinase (MMP) activity, and (ii) an epithelial–mesenchymal transition leading to a weaker
attachment to extracellular matrix (ECM) molecules (such as matrigel components) due to the
downregulation of genes involved in cell–ECM adhesion and cell–cell junctions [23]. Both aspects
support cell infiltration and crossing through the three-dimensional matrigel layer.
Among the enzymes that use Mn as a cofactor, manganese superoxide dismutase (MnSOD)
is a likely candidate as responsible of the observed effect. MnSOD is a mitochondrial tetrameric
protein contributing to the maintenance of redox balance and intact respiratory function via the
dismutation of the superoxide radical to oxygen and hydrogen peroxide, the latter being subsequently
metabolized by hydrogen peroxide-detoxifying enzymes [24]. High levels of MnSOD gene (i.e., SOD2)
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expression have been found in different cancers and correlated to poor prognosis, low relapse-free
survival and overall survival rate. Concerning breast cancer, SOD2 expression levels are different
in the various histotypes, being upregulated in both tissue specimens and cell lines derived from
the more “aggressive” basal-like, claudin low-, and estrogen receptor-negative subtype, including
MDA-MB231 [25]. Kattan et al. [26] reported that the elevated expression level of SOD2 in
MDA-MB231 cells is coupled to a downregulation of the detoxifying enzymes, thereby resulting
in an accumulation of hydrogen peroxide, which, in turn, stimulates cell growth via activation of the
MAPK-dependent signalization and transcription factors such as NF-κB and AP-1. Conversely, low
levels of MnSOD protein were found in nontumoral breast epithelial cell lines, such as MCF-10A [27].
A number of experimental evidence has demonstrated that, apart from upregulating MnSOD activity,
Mn promotes SOD2 expression in different biological systems [28,29], including Hs578T TNBC
cells [30]. Therefore, it is conceivable that exposure of MDA-MB231 cells to MnCl2 may determine
an additional dose- and time-dependent upregulation of MnSOD with consequent increase of cell
number. Moreover, by analogy with Hs578T line which was induced to death by MnCl2 above 100 µM,
such concentration impaired also MDA-MB231 cell viability and proliferation. As hypothesized by
Thongphasuk et al. [30], such an effect could be due to excess of free radicals and/or high glucose
consumption during the redox cycle to supply reducing equivalents. On the other hand, similarly to
what was found for the syngeneic Hs578Bst cell line derived from adjacent normal tissue, no effect
was exerted by MnCl2 treatment on nontumoral HB2 cells, apart from the intoxication at high
concentration of the compound as for tumor cells. Such insensitivity might be explained in light
of (i) the demonstrated heterogeneity of cell-specific SOD2 stimulants resulting in the inability of Mn
to upregulate the enzymatic activity in certain cytotypes, (ii) the low levels of MnSOD enzyme which
may be saturated at nanomolar concentrations of Mn without further dose-dependent stimulation
of enzyme function, as reported by [28], and/or (iii) the presence of a more efficient hydrogen
peroxide-detoxifying apparatus [30].
The involvement of MnSOD in cell invasive activity is also widely recognized. Nelson et al. [31]
demonstrated the association between the elevated MnSOD enzymatic activity and the upregulation
of general MMP expression in HT-1080 fibrosarcoma cells via the hydrogen peroxide-triggered
increase of the DNA-binding activity of specific transcription factors. The migratory phenotype
of these tumor cells, linked to cytoskeletal reorganization, lamellipodia extension, and disruption
of focal adhesions, have been also associated to hydrogen peroxide-mediated modulation of Rac
and Rho-mediated signal transduction [32]. Concerning MDA-MB231 cells, MnSOD expression was
found positively correlated to the epithelial–mesenchymal transition responsible of their invasive and
migratory capacities [33]. In line with literature data, the present results demonstrate that MDA-MB231
cells show an approximately threefold increase of their R.I.I. in the presence of 5 µM MnCl2, which is
attributable to an elevation of motile activity and erosive capacity towards matrigel. On the other hand,
the results obtained with cells cultured in 100 µM MnCl2-containing medium indicate that, although
the R.I.I. underwent a faint lowering, tumor cells still retain an active motile behavior on matrigel-free
filters, even greater than controls, thereby suggesting that Mn regulation of viability/growth rate,
locomotory stimulation, and release of ECM-targeted enzymes may rely upon different intracellular
pathways and mechanisms.
Cd is a nonessential element with a long biological half-life of ~25 years in the human body. It is
not involved in enzymatic activities but it was shown to interfere with zinc-dependent intracellular
processes, due to their many chemical similarities. Several literature reports have brought evidence
about the inhibitory potential of Mn supplementation on intracellular Cd uptake thereby playing
a major role in tissue protection from Cd toxicity. Competition for both binding sites at the plasma
membrane and transmembrane transport systems, and inhibition of Cd-induced reactive oxygen
species (ROS) production, lipid peroxidation, and ERK activation are considered as the main reasons
for the Mn-dependent alleviation of Cd effect [3,4,14–16,34–36]. Concerning TNBC MDA-MB231 cells,
our previous data demonstrated the dose-dependent cytotoxic effect of CdCl2 with an IC50 at 96 h
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of 5 µM concentration. Subsequent molecular studies demonstrated that this treatment induced the
upregulation of cellular defense genes such as those coding for Dap kinase and some members of
cytosolic/mitochondrial heat shock proteins, caspases, and metallothioneins, and the downregulation
of the genes coding for the survival factor Bcl-2, the NF-κB-stimulating AEG-1 protein, and the
cytochrome oxidase subunits II and IV. Moreover, an abnormally increased rate of mitochondrial
respiration, a massive accumulation of ROS and a derangement of MAPK pattern of expression and
synthesis was also found in exposed cells [17–19,37]. To our knowledge, here we present first data
focusing on the mitigating activity of Cd on Mn-induced exacerbation of TNBC cell proliferative
and invasive behavior. In fact, the addition of 5 µM CdCl2 to the medium containing the different
MnCl2 concentrations counteracted the increase of cell number diminishing cell viability/growth rate
down to values close to those attributable to the effect of the sole CdCl2. Also, the R.I.I. of coexposed
cells decreased drastically with respect to controls. Given that MnSOD is strictly localized into the
mitochondria and that the MAPK signaling pathway is responsible of the Mn-triggered proliferative
activity [26], it is conceivable that the previously observed alterations induced by Cd to mitochondria
and MAPK signalization in MDA-MB231 cells may be, at least in part, responsible of the suppression of
the promoting effects of MnCl2 in the case of cotreatment. Other non-MnSOD-dependent mechanisms
may be responsible of the observed effects. In fact, it must be taken into consideration that Cd and Mn
share a common pathway for entering the cells through transmembrane transport systems and that
competition between the two metal has been reported [3,4]. In addition, data have been produced on
the competitive inhibition played by Cd on Mn-binding active sites in different enzymes and other
intracellular targets [34,35,38].
4. Materials and Methods
4.1. Cell Cultures
MDA-MB231 TNBC cells and HB2 immortalized breast epithelial cells [39] (the latter courtesy
of Cancer Research, UK), taken from laboratory stocks, were cultured in RPMI 1640 medium
(MDA-MB231) and high glucose–DMEM medium plus 5 µg hydrocortisone/mL and 10 µg bovine
insulin/mL (HB2), respectively, both purchased from Sigma, St. Louis, MO, USA, supplemented with
10% fetal calf serum (FCS; ThermoFisher, Waltham MA, USA) and antibiotic/antimycotic mixture
(100 U/mL penicillin, 100 µg/mL streptomycin, and 2.5 mg/L amphotericin B; ThermoFisher), at 37 ◦C
in a 5% CO2 atmosphere. Since the only Mn source in routine culture is FCS where the metal is present
in varying concentrations, its percentage in the tumor cell-containing media was lowered to 1% 4 h
before the proliferation assays and maintained at this concentration during the tests. On the other
hand, no reduction of serum concentration was made for HB2 cells due to the demonstrated strong
dependency of these cells on 10% FCS supplement for their sustained growth rate [40].
4.2. Proliferation Assay
Cell proliferative behavior was evaluated by crystal violet assay [41]. Cells in exponential growth
were plated at a concentration of 5500 cells/well in a 96-well plate, allowed to adhere overnight,
and then treated for 24, 48, 72, and 96 h with 1, 5, 10, 50, or 100 µM MnCl2. A parallel set of assays
was made by exposing cells to the above-mentioned concentrations of MnCl2 in association with 5 µM
CdCl2. At the end of the incubation cells were stained with 0.2% crystal violet in 2% ethanol for 10 min,
followed by elution of the bound dye with 1% SDS. The absorbance of the dissolved crystal violet was
measured in an automated microplate reader at 570 nm.
4.3. In Vitro Chemotaxis and Chemoinvasion Assays
Cell motile and invasive behaviors were evaluated by a modified Boyden chamber test, essentially
as described by [9]. Each “blind well” chamber (top well = 800 µL, bottom well = 200 µL; Neuro-Probe,
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Cabin John, MD, USA) accommodated a polyvinylpyrrolidone-free filter polycarbonate filter with
an 8-µM pore diameter and 50 mm2 exposed area (Nucleopore, Pleasanton, CA/USA).
For chemotaxis assays, in order to optimize cell adhesion, the plastic filters were coated with
type I collagen (Sigma, St. Louis, MO, USA) dissolved in 0.1% acetic acid at the concentration
of 20 µg/mL and allowed to dry overnight [42]. For chemoinvasion assays, the filters were
coated with 25 µg of matrigel, a reconstituted three-dimensional basement membrane matrix from
Engelbreth–Holm–Swarm murine sarcoma (Sigma, St. Louis, MO, USA).
Before the assays, the cells were treated with MnCl2, CdCl2, or both, at the concentrations and
for the times which were shown to affect their proliferative behavior, as from the previous assay.
Trypsinized control and treated cells were resuspended in FCS-deprived medium after exhaustive
washing and seeded at the concentration of 3 × 105 in the upper well of the chamber, whereas fresh
10% FCS-containing medium was used as chemoattractant in the lower well, as reported by Kamath
and coworkers for MDA-MB231 and MCF-7 breast cancer cells [43]. The assays were carried out for
6 h, and after removal of the nonmigrated cells attached to the upper surface of the filters with a cotton
swab, those migrated to the lower surface of the filter were fixed with 95% ethanol, stained with 0.02 g
toluidine blue/mL, and quantified by counting their number in twelve random fields of the filter at
200-fold magnification, after mounting the filters onto microscope slides with a drop of immersion oil.
The I.I. and the R.I.I. were calculated as follows
I.I. = NCI/NCT × 100
where NCI and NCT were the number of control or treated cells crossing the filters in parallel
chemoinvasion and chemotaxis assays, respectively.
R.I.I. = I.I.t/I.I.c
where I.I.t and I.I.c were the I.I. of treated and control cells, respectively. R.I.I. values = 1, <1, and >1 are
indicative of invasion-ineffective, -restraining, and -promoting effects exerted by the specific treatment,
respectively.
4.4. Statistics
Statistics was checked through ANOVA test with SigmaStat 4.0 software (SYSTAT, San Jose,
CA, USA). A p-value < 0.05 was considered statistically significant.
5. Conclusions
Although caution must be exercised in extrapolation of in vitro results to the in vivo situation, the
present data further support the concept that human exposure to high environmental concentrations
of Mn may increase the risk of accelerating the processes of carcinogenesis and metastasis by
prompting the expansion and dissemination of subpopulations of overtly transformed TNBC cells,
in line with the findings described in a number of epidemiological reports [7,44,45]. Interestingly,
CdCl2 treatment appears to possess the potential to counteract MnCl2-mediated cancer-promoting
effects. This might be achieved by cotargeting cellular sites and components, and reprogramming
the molecular and biochemical pathways of MnCl2-stimulated TNBC cells. The inhibitory activity of
Cd-containing compounds on viability and growth of normal and neoplastic cells and the mitigatory
effect provided by Zn-containing molecules have been reported in the literature [46–48]. Taking the
limited treatment options against TNBC into account, the specific anticancer modulatory property
of CdCl2 towards MDA-MB231 cells here reported looks promising and deserves a more detailed
biological characterization of the involved intracellular targets aimed to the possible molecular
modeling of specific antineoplastic agents with improved effectiveness towards the inhibition of
the spreading of malignant breast cancer.
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